You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

SORINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sorine, and when can generic versions of Sorine launch?

Sorine is a drug marketed by Aiping Pharm Inc and is included in one NDA.

The generic ingredient in SORINE is sotalol hydrochloride. There are ten drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sorine

A generic version of SORINE was approved as sotalol hydrochloride by TEVA on May 1st, 2000.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SORINE?
  • What are the global sales for SORINE?
  • What is Average Wholesale Price for SORINE?
Drug patent expirations by year for SORINE
Drug Prices for SORINE

See drug prices for SORINE

Pharmacology for SORINE
Drug ClassAntiarrhythmic
Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectCardiac Rhythm Alteration

US Patents and Regulatory Information for SORINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aiping Pharm Inc SORINE sotalol hydrochloride TABLET;ORAL 075500-001 Apr 27, 2001 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aiping Pharm Inc SORINE sotalol hydrochloride TABLET;ORAL 075500-003 Apr 27, 2001 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aiping Pharm Inc SORINE sotalol hydrochloride TABLET;ORAL 075500-004 Apr 27, 2001 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aiping Pharm Inc SORINE sotalol hydrochloride TABLET;ORAL 075500-002 Apr 27, 2001 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.